Hepatic lipid profiling in chronic hepatitis C: An in vitro and in vivo proton magnetic resonance spectroscopy study

Journal of Hepatology

Volumn 52, Issue 1, 2010, Pages 16-24

  Cobbold, Jeremy F L ^a   Patel, Jaymin H ^a   Goldin, Robert D ^a   North, Bernard V ^a   Crossey, Mary M E ^a   Fitzpatrick, Julie ^a   Wylezinska, Marzena ^a   Thomas, Howard C ^a   Cox, I Jane ^a   Taylor Robinson, Simon D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Lipid; Liver; Metabolic; MR spectroscopy; Non invasive; Steatosis

Indexed keywords

CHOLESTEROL; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIPID LIVER LEVEL; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO;

ADOLESCENT; ADULT; AGED; BIOPSY; COHORT STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIPID METABOLISM; LIPIDS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTONS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 71249105685     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.10.006     Document Type: Article

References (44)

1. Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.F., Utili R., and Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33 (2001) 1358-1364
2. Rubbia-Brandt L., Fabris P., Paganin S., Leandro G., Male P.J., Giostra E., et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 53 (2004) 406-412
3. Reddy K.R., Govindarajan S., Marcellin P., Bernstein D., Dienstag J.L., Bodenheimer Jr. H., et al. Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. J Viral Hepat 15 (2008) 129-136
4. Rubbia-Brandt L., Quadri R., Abid K., Giostra E., Male P.J., Mentha G., et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33 (2000) 106-115
5. Hourioux C., Patient R., Morin A., Blanchard E., Moreau A., Trassard S., et al. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut 56 (2007) 1302-1308
6. Hui J.M., Sud A., Farrell G.C., Bandara P., Byth K., Kench J.G., et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 125 (2003) 1695-1704
7. Camma C., Bruno S., Di Macro V., Di Bona D., Rumi M., Vinci M., et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 43 (2006) 64-71
8. Asselah T., Rubbia-Brandt L., Marcellin P., and Negro F. Steatosis in chronic hepatitis C: why does it really matter?. Gut 55 (2006) 123-130
9. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
10. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
11. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
12. Szczepaniak L.S., Nurenberg P., Leonard D., Browning J.D., Reingold J.S., Grundy S., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005) E462-E468
13. Thomas E.L., Hamilton G., Patel N., O'Dwyer R., Dore C.J., Goldin R.D., et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54 (2005) 122-127
14. Musso G., Gambino R., De Michieli F., Cassader M., Rizzetto M., Durazzo M., et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37 (2003) 909-916
15. Wang D., Wei Y., and Pagliassotti M.J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147 (2006) 943-951
16. Serkova N.J., Jackman M., Brown J.L., Liu T., Hirose R., Roberts J.P., et al. Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol 44 (2006) 956-962
17. Cobbold J.F., Anstee Q.M., Goldin R.D., Williams H.R., Matthews H.C., North B.V., et al. Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin Sci (Lond) 116 5 (2009) 403-413
18. Cabre E., and Gassull M.A. Polyunsaturated fatty acid deficiency in liver diseases: pathophysiological and clinical significance. Nutrition 12 (1996) 542-548
19. Kleiner D.E., Brunt E.M., Van N.M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
20. Martinez-Granados B., Monleon D., Martinez-Bisbal M.C., Rodrigo J.M., del Olmo J., Lluch P., et al. Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy. NMR Biomed 19 (2006) 90-100
21. Bollard M.E., Garrod S., Holmes E., Lindon J.C., Humpfer E., Spraul M., et al. High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn Reson Med 44 (2000) 201-207
22. Duarte I.F., Stanley E.G., Holmes E., Lindon J.C., Gil A.M., Tang H., et al. Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem 77 (2005) 5570-5578
23. Rooney O.M., Troke J., Nicholson J.K., and Griffin J.L. High-resolution diffusion and relaxation-edited magic angle spinning 1H NMR spectroscopy of intact liver tissue. Magn Reson Med 50 (2003) 925-930
24. Naressi A., Couturier C., Devos J.M., Janssen M., Mangeat C., de Beer R., et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 12 (2001) 141-152
25. Vanhamme L., van den B.A., and Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129 (1997) 35-43
26. Hamilton G., Patel N., Forton D.M., Hajnal J.V., and Taylor-Robinson S.D. Prior knowledge for time domain quantification of in vivo brain or liver 31P MR spectra. NMR Biomed 16 (2003) 168-176
27. Johnson N.A., Walton D.W., Sachinwalla T., Thompson C.H., Smith K., Ruell P.A., et al. Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 47 (2008) 1513-1523
28. Longo R., Pollesello P., Ricci C., Masutti F., Kvam B.J., Bercich L., et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5 (1995) 281-285
29. Cho S.G., Kim M.Y., Kim H.J., Kim Y.S., Choi W., Shin S.H., et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221 (2001) 740-746
30. Orlacchio A., Bolacchi F., Cadioli M., Bergamini A., Cozzolino V., Angelico M., et al. Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy. AJR Am J Roentgenol 190 (2008) 1331-1339
31. Lim A.K., Hamilton G., Patel N., Bell J.D., and Taylor-Robinson S.D. H MR spectroscopy in the evaluation of the severity of chronic liver disease. Radiology 226 (2003) 288-289
32. Cobbold J.F., Taylor-Robinson S.D., and Cox I.J. In vitro proton magnetic resonance spectroscopy of liver tissue informs in vivo hepatic proton magnetic resonance spectroscopy studies. Hepatology 48 (2008) 1016-1017
33. Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chretien Y., et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 16 (2002) 185-194
34. Waris G., Felmlee D.J., Negro F., and Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 81 (2007) 8122-8130
35. Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Tsukamoto K., Kimura S., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126 (2004) 840-848
36. Puri P., Baillie R.A., Wiest M.M., Mirshahi F., Choudhury J., Cheung O., et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46 (2007) 1081-1090
37. Yao Z.M., and Vance D.E. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 263 (1988) 2998-3004
38. Noga A.A., Zhao Y., and Vance D.E. An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J Biol Chem 277 (2002) 42358-42365
39. Walkey C.J., Yu L., Agellon L.B., and Vance D.E. Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem 273 (1998) 27043-27046
40. Kapadia S.B., and Chisari F.V. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA 102 (2005) 2561-2566
41. Okuda M., Li K., Beard M.R., Showalter L.A., Scholle F., Lemon S.M., et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 (2002) 366-375
42. Paradis V., Mathurin P., Kollinger M., Imbert-Bismut F., Charlotte F., Piton A., et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 50 (1997) 401-406
43. Diamond D.L., Jacobs J.M., Paeper B., Proll S.C., Gritsenko M.A., Carithers Jr. R.L., et al. Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. Hepatology 46 (2007) 649-657
44. Fischbach F., and Bruhn H. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int 28 (2008) 297-307